Member access

4-Traders Homepage  >  Shares  >  Xetra  >  CytoTools AG    T5O   DE000A0KFRJ1

CYTOTOOLS AG (T5O)

7
Real-time Quote. Real-time TRADEGATE AG - 01/23 10:01:52 pm
60.1500 EUR   0.00%
2014 CYTOTOOLS : DermaPro
2014 CYTOTOOLS : Clinical development
2014 CYTOTOOLS : Annual General Meeting 2014
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra
01/19/2015 01/20/2015 01/21/2015 01/22/2015 01/23/2015 Date
57.97(c) 58.25(c) 58.9(c) 58.3(c) 60.15(c) Last
584 2 897 1 407 262 6 270 Volume
+0.14% +0.48% +1.12% -1.02% +3.17% Change
More quotes
Company
CytoTools AG operates as a technology and associated company, which is engaged in the purchase, management and sale of shareholdings in German technology enterprises.It focuses on investing in enterprises from the health sector, active in the area of research and development of medicaments and... 
More about the company
Chart CYTOTOOLS AG
Duration : Period :
CytoTools AG Technical Analysis Chart | T5O | DE000A0KFRJ1 | 4-Traders
Full-screen chart
Financials (€)
Sales 2014 0,80 M
EBIT 2014 -0,92 M
Net income 2014 -0,92 M
Finance 2014 2,50 M
Yield 2014 -
Sales 2015 11,8 M
EBIT 2015 6,75 M
Net income 2015 3,84 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015 29,78
Capi. / Sales 2014 140x
Capi. / Sales 2015 9,72x
Capitalization 114 M
More Financials
Latest news on CYTOTOOLS AG
2014 CYTOTOOLS : DermaPro
2014 CYTOTOOLS : Clinical development
2014 CYTOTOOLS : Clinical development of wound healing drug DermaPro(R) progressing o..
2014 CYTOTOOLS : Annual General Meeting 2014
2014 CYTOTOOLS : Annual General Meeting elects new Supervisory Board members (DGAP Ne..
2014 CYTOTOOLS : Capital Increase CytoPharma GmbH
2014 CYTOTOOLS : adds cardiovascular and further indications to its field of interest..
2014 CYTOTOOLS : strengthens successful subsidiary DermaTools Biotech GmbH with furth..
More news
Sector news Bio Therapeutic Drugs
01/23 INCYTE : Earns $25 Million Milestone as Jakavi® (ruxolitinib) Recommended for Ap..
01/23 MEDIVATION : Astellas -enzalutamide phase 2 terrain trial demonstrated statistic..
01/22 QUINTILES TRANSNATIONAL : Investigator Initiated Trials is Topic of New Handbook..
Plus d'actualités du secteur Bio Therapeutic Drugs


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF